Stay updated on Deucravacitinib in Active Psoriatic Arthritis: Clinical Trial

Sign up to get notified when there's something new on the Deucravacitinib in Active Psoriatic Arthritis: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Deucravacitinib in Active Psoriatic Arthritis: Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Revision: v3.3.2 was added and Revision: v3.2.0 was removed, appearing as metadata on the page, and these updates do not modify the study details or any user-facing content (To avoid being alerted by small changes, set an alert condition by clicking below).
    Difference
    0.2%
    Check dated 2025-11-24T17:05:51.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Location entries updated: Tainan City entries for site 704 and 710 were replaced with 'Tainan, Taiwan, 704' and 'Tainan, Taiwan, 710', and the two new Taiwan sites were added. A government funding status notice was removed.
    Difference
    0.2%
    Check dated 2025-11-17T15:04:16.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Added the labels 'Results First Posted (Estimated)' and 'Last Update Posted (Estimated)' in the Study Record Dates; removed the non-estimated 'Results First Posted' and 'Last Update Posted' entries.
    Difference
    0.2%
    Check dated 2025-11-03T01:30:41.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Results have been posted with detailed efficacy and patient-reported outcome measures (e.g., ACR 20 at Week 16, PASI, HAQ-DI, DAS28-CRP, SF-36, PsAID, DAPSA, PsARC, BASDAI, SvdH, etc.). The Cali, Colombia site entry was updated to indicate Cali (760042), replacing the previous Santiago de Cali listing.
    Difference
    4%
    Check dated 2025-10-26T20:52:16.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The page updates to v3.2.0 and adds a government funding operating-status notice, replacing the previous v3.1.0 reference.
    Difference
    2%
    Check dated 2025-10-05T10:34:18.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    Page now shows Revision: v3.1.0 and removes several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) from the content; core page content appears to be re-scoped rather than expanded.
    Difference
    0.2%
    Check dated 2025-09-28T03:27:31.000Z thumbnail image

Stay in the know with updates to Deucravacitinib in Active Psoriatic Arthritis: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Deucravacitinib in Active Psoriatic Arthritis: Clinical Trial page.